172 related articles for article (PubMed ID: 8099528)
1. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer.
McKenzie SJ; DeSombre KA; Bast BS; Hollis DR; Whitaker RS; Berchuck A; Boyer CM; Bast RC
Cancer; 1993 Jun; 71(12):3942-6. PubMed ID: 8099528
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy.
Meden H; Marx D; Fattahi A; Rath W; Kron M; Wuttke W; Schauer A; Kuhn W
J Cancer Res Clin Oncol; 1994; 120(6):378-81. PubMed ID: 7908021
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis.
Rubin SC; Finstad CL; Wong GY; Almadrones L; Plante M; Lloyd KO
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):162-9. PubMed ID: 8093588
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
5. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
[TBL] [Abstract][Full Text] [Related]
6. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Her2/Neu Protein Expression in Ovarian Epithelial Cancers.
Jafri A; Rizvi S
J Coll Physicians Surg Pak; 2017 Sep; 27(9):544-546. PubMed ID: 29017668
[TBL] [Abstract][Full Text] [Related]
8. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
9. Oral cancer progression and c-erbB-2/neu proto-oncogene expression.
Hou L; Shi D; Tu SM; Zhang HZ; Hung MC; Ling D
Cancer Lett; 1992 Aug; 65(3):215-20. PubMed ID: 1355405
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Berchuck A; Kamel A; Whitaker R; Kerns B; Olt G; Kinney R; Soper JT; Dodge R; Clarke-Pearson DL; Marks P
Cancer Res; 1990 Jul; 50(13):4087-91. PubMed ID: 1972347
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of serum c-erbB-2 in patients with ovarian masses.
Cheung TH; Wong YF; Chung TK; Maimonis P; Chang AM
Gynecol Obstet Invest; 1999; 48(2):133-7. PubMed ID: 10461006
[TBL] [Abstract][Full Text] [Related]
12. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
Slamon DJ; Godolphin W; Jones LA; Holt JA; Wong SG; Keith DE; Levin WJ; Stuart SG; Udove J; Ullrich A
Science; 1989 May; 244(4905):707-12. PubMed ID: 2470152
[TBL] [Abstract][Full Text] [Related]
13. Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers.
Wu JT; Astill ME; Zhang P
J Clin Lab Anal; 1993; 7(1):31-40. PubMed ID: 8093903
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
Cohen JA; Weiner DB; More KF; Kokai Y; Williams WV; Maguire HC; LiVolsi VA; Greene MI
Oncogene; 1989 Jan; 4(1):81-8. PubMed ID: 2563577
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
16. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer.
Rubin SC; Finstad CL; Federici MG; Scheiner L; Lloyd KO; Hoskins WJ
Cancer; 1994 Mar; 73(5):1456-9. PubMed ID: 7906607
[TBL] [Abstract][Full Text] [Related]
18. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
[TBL] [Abstract][Full Text] [Related]
19. The neu-oncogene product in serum and tissue of patients with breast carcinoma.
Kath R; Höffken K; Otte C; Metz K; Scheulen ME; Hülskamp F; Seeber S
Ann Oncol; 1993 Aug; 4(7):585-90. PubMed ID: 8103351
[TBL] [Abstract][Full Text] [Related]
20. Rare expression of the c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study.
Shrestha P; Huang JW; Tsuji T; Shinozaki F; Maeda K; Sasaki K; Ueno K; Yamada K; Mori M
J Oral Pathol Med; 1992 Nov; 21(10):477-80. PubMed ID: 1361005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
